Transactivation of the IGF-1R by aldosterone

被引:20
|
作者
Holzman, Jennifer L.
Liu, Lian
Duke, Billie Jeanne
Kemendy, Alexandra E.
Eaton, Douglas C.
机构
[1] Emory Univ, Sch Med, Dept Physiol, Ctr Cell & Mol Signaling, Atlanta, GA 30322 USA
[2] Emory Univ, Grad Sch Arts & Sci, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA
关键词
PI3-kinase; insulin-like growth factor-1; Akt; A6; cells;
D O I
10.1152/ajprenal.00214.2006
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Activation of epithelial sodium channels (ENaC) by aldosterone, insulin, or insulin-like growth factor 1 (IGF-1) in renal epithelial cells (including the Xenopus laevis renal cell line A6) appears to share some common signaling elements subsequent to the initial insulin or IGF-1 receptor activation. Previously, the convergence point for insulin or IGF-1 and aldosterone signaling was assumed to be downstream of the receptor at the level of phosphatidylinositol 3-kinase (PI3-K); however, this study shows aldosterone directly transactivates the IGF-1 receptor (IGF-1R). In A6 cells, 10-min exposure to aldosterone increased the phosphorylation of the IGF- 1 receptor, insulin receptor substrate-1 (IRS-1), and Akt (PKB). Furthermore, aldosterone activated PI3-K and phosphorylation of the most downstream element, Akt, was blocked by the specific PI3-K inhibitor LY-294002. Transactivation requires aldosterone binding to the mineralocorticoid/glucocorticoid receptor and does not require transcription.
引用
收藏
页码:F1219 / F1228
页数:10
相关论文
共 50 条
  • [1] Transactivation of the IGF-1 receptor (IGF-1R) by aldosterone
    Holzman, JL
    Liu, L
    Eaton, DC
    FASEB JOURNAL, 2005, 19 (05): : A1178 - A1178
  • [2] Transactivation of the IGF-1R by aldosterone is MR mediated, but transcriptionally independent, and involves activation of Src kinase
    Holzman, JL
    Eaton, DC
    FASEB JOURNAL, 2006, 20 (04): : A347 - A347
  • [3] Blockade of Peripheral IGF-1R with IGF-1R Antagonist Antibody.
    Kong, M.
    Huffman, D. M.
    Barzilai, N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 213 - 213
  • [4] SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors
    Zimmermann, Kurt
    Wittman, Mark D.
    Saulnier, Mark G.
    Velaparthi, Upender
    Sang, Xiaopeng
    Frennesson, David B.
    Struzynski, Charles
    Seitz, Steven P.
    He, Liqi
    Carboni, Joan M.
    Li, Aixin
    Greer, Ann F.
    Gottardis, Marco
    Attar, Ricardo M.
    Yang, Zheng
    Balimane, Praveen
    Discenza, Lorell N.
    Lee, Francis Y.
    Sinz, Michael
    Kim, Sean
    Vyas, Dolatrai
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1744 - 1748
  • [5] IGF-1R inhibitors
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S150 - S150
  • [6] IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-)
    Rosengren, Linda
    Vasilcanu, Daiana
    Vasilcanu, Radu
    Fickenscher, Sandra
    Sehat, Bita
    Natalishvili, Nathalia
    Naughton, Sean
    Yin, Shucheng
    Girnita, Ada
    Girnita, Leonard
    Axelson, Magnus
    Larsson, Olle
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (04) : 1059 - 1066
  • [7] Allosteric IGF-1R Inhibitors
    Heinrich, Timo
    Graedler, Ulrich
    Boettcher, Henning
    Blaukat, Andree
    Shutes, Adam
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (05): : 199 - 203
  • [8] Inhibition of IGF-1R and sarcomas
    Massard, Christophe
    Blay, Jean-Yves
    BULLETIN DU CANCER, 2010, 97 (08) : 895 - 895
  • [9] Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
    Lerner, Lorena
    Liu, Qing
    Tao, Nianjun
    Yang, John
    Brown, Eric
    Koujak, Susan
    Krieger, Brian
    Huang, Lu
    Rosenfeld-Franklin, Maryland
    Miglarese, Mark
    Pachter, Jonathan
    Robinson, Murray O.
    Chiu, M. Isabel
    Epstein, David
    Buck, Elizabeth
    CANCER RESEARCH, 2011, 71
  • [10] Inhibition of IGF-1R in adrenocortical carcinoma
    Kirschner, Lawrence S.
    LANCET ONCOLOGY, 2015, 16 (04): : 356 - +